Scarica l'app Stockscreener
7.51
1.05%
-0.08
Dopo l'orario di chiusura:
7.51
Precedente Chiudi:
$7.59
Aprire:
$7.59
Volume 24 ore:
893.90K
Relative Volume:
0.58
Capitalizzazione di mercato:
$769.26M
Reddito:
-
Utile/perdita netta:
$-167.48M
Rapporto P/E:
-3.8513
EPS:
-1.95
Flusso di cassa netto:
$-197.47M
1 W Prestazione:
+4.31%
1M Prestazione:
+7.44%
6M Prestazione:
-20.40%
1 anno Prestazione:
-45.06%
Intervallo 1D:
$7.405
$7.61
Intervallo di 1 settimana:
$6.9334
$7.735
Portata 52W:
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Nome
Day One Biopharmaceuticals Inc
Settore
Industria
Telefono
650 484-0899
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Confronta DAWN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.51 | 777.46M | 0 | -167.48M | -197.47M | -1.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-10-09 | Reiterato | Needham | Buy |
| 2024-08-01 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-04-24 | Reiterato | Needham | Buy |
| 2023-04-25 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-08 | Iniziato | CapitalOne | Overweight |
| 2023-02-03 | Iniziato | Oppenheimer | Perform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-14 | Iniziato | Needham | Buy |
| 2022-12-05 | Iniziato | Goldman | Buy |
| 2022-12-01 | Iniziato | BofA Securities | Buy |
Mostra tutto
Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie
Is Day One Biopharmaceuticals Inc.’s growth already priced in2025 Investor Takeaways & Low Volatility Stock Suggestions - خودرو بانک
Is Day One Biopharmaceuticals Inc. stock a good dividend stockQuarterly Earnings Report & Safe Entry Point Identification - خودرو بانک
Reversal indicators forming on Day One Biopharmaceuticals Inc. stockPortfolio Profit Report & Fast Moving Stock Watchlists - Newser
Should you wait for a breakout in Day One Biopharmaceuticals Inc.Short Setup & Daily Volume Surge Trade Alerts - Newser
Sentiment analysis tools applied to Day One Biopharmaceuticals Inc.July 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Day One Biopharmaceuticals Inc. stock daily chart insightsQuarterly Trade Report & Daily Growth Stock Tips - Newser
Identifying reversal signals in Day One Biopharmaceuticals Inc.Weekly Trade Review & Verified Chart Pattern Trade Signals - Newser
How to build a dashboard for Day One Biopharmaceuticals Inc. stockWeekly Market Outlook & Safe Entry Trade Signal Reports - Newser
Can Day One Biopharmaceuticals Inc. Regain Momentum After Breakdown getLinesFromResByArray error: size == 0 - newsyoung.net
Analyzing drawdowns of Day One Biopharmaceuticals Inc. with statistical toolsMarket Trend Summary & Reliable Momentum Entry Alerts - Newser
Real time breakdown of Day One Biopharmaceuticals Inc. stock performance2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
Can swing trading help recover from Day One Biopharmaceuticals Inc. lossesPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Analyzing Day One Biopharmaceuticals Inc. with risk reward ratio chartsNew Guidance & High Accuracy Trade Signal Alerts - Newser
Is this a good reentry point in Day One Biopharmaceuticals Inc.Market Risk Summary & Capital Protection Trade Alerts - Newser
Applying sector rotation models to LKFNJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser
Best data tools to analyze Day One Biopharmaceuticals Inc. stockJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Day One Biopharmaceuticals Inc. Enters Reversal Setup in Weekly Charts2025 Market Outlook & High Conviction Buy Zone Picks - beatles.ru
How to use Fibonacci retracement on Day One Biopharmaceuticals Inc.July 2025 Summary & Safe Capital Preservation Plans - Newser
Regression analysis insights on Day One Biopharmaceuticals Inc. performanceBond Market & Smart Investment Allocation Insights - Newser
Does Day One Biopharmaceuticals Inc. qualify in momentum factor screeningPortfolio Value Report & Stepwise Trade Execution Plans - Newser
Analyzing net buyer seller activity in Day One Biopharmaceuticals Inc.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Using data tools to time your Day One Biopharmaceuticals Inc. exitJuly 2025 Levels & Weekly High Momentum Picks - Newser
What technical models suggest about Day One Biopharmaceuticals Inc.’s comeback - Newser
Will Day One Biopharmaceuticals Inc. bounce back from current supportEntry Point & Daily Technical Forecast Reports - Newser
Trend analysis for Day One Biopharmaceuticals Inc. this weekSell Signal & Real-Time Volume Trigger Notifications - Newser
Technical signs of recovery in Day One Biopharmaceuticals Inc.2025 Market WrapUp & Precise Buy Zone Identification - Newser
What is Day One Biopharmaceuticals Inc. s P E ratio telling usWeekly Gains Summary & Safe Entry Momentum Stock Tips - sundaytimes.kr
Combining machine learning predictions for Day One Biopharmaceuticals Inc.2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Day One Biopharmaceuticals Inc Azioni (DAWN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Day One Biopharmaceuticals Inc Azioni (DAWN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dubow Adam | Gen Counsel & Secretary |
Aug 18 '25 |
Sale |
6.77 |
4,365 |
29,538 |
54,858 |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER |
Aug 18 '25 |
Sale |
6.77 |
16,058 |
108,666 |
161,365 |
| Merendino Lauren | Chief Commercial Officer |
Aug 18 '25 |
Sale |
6.77 |
3,766 |
25,485 |
41,931 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):